
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4964872
[patent_doc_number] => 20080107692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DETECTION OF TRYPANOSOMA CRUZI INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/743534
[patent_app_country] => US
[patent_app_date] => 2007-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10061
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107692.pdf
[firstpage_image] =>[orig_patent_app_number] => 11743534
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/743534 | COMPOSITIONS AND METHODS FOR THE DETECTION OF TRYPANOSOMA CRUZI INFECTION | May 1, 2007 | Abandoned |
Array
(
[id] => 4886445
[patent_doc_number] => 20080260777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'COMPOSITION AND METHOD FOR CONTROLLING INTESTINAL PATHOGENIC ORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 11/737483
[patent_app_country] => US
[patent_app_date] => 2007-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4080
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260777.pdf
[firstpage_image] =>[orig_patent_app_number] => 11737483
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/737483 | COMPOSITION AND METHOD FOR CONTROLLING INTESTINAL PATHOGENIC ORGANISMS | Apr 18, 2007 | Abandoned |
Array
(
[id] => 5115185
[patent_doc_number] => 20070199101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Nucleic Acid Molecules Encoding Cyclotide Polypeptides and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 11/736633
[patent_app_country] => US
[patent_app_date] => 2007-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25016
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20070199101.pdf
[firstpage_image] =>[orig_patent_app_number] => 11736633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/736633 | Nucleic acid molecules encoding cyclotide polypeptides and methods of use | Apr 17, 2007 | Issued |
Array
(
[id] => 91751
[patent_doc_number] => 07732187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Recombinant attenuated clostridium organisms and vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/734454
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 12799
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732187.pdf
[firstpage_image] =>[orig_patent_app_number] => 11734454
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/734454 | Recombinant attenuated clostridium organisms and vaccine | Apr 11, 2007 | Issued |
Array
(
[id] => 6351590
[patent_doc_number] => 20100021926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'METHOD FOR RAPID DETECTION OF LYMPHATIC FILARIASIS'
[patent_app_type] => utility
[patent_app_number] => 12/297325
[patent_app_country] => US
[patent_app_date] => 2007-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3890
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021926.pdf
[firstpage_image] =>[orig_patent_app_number] => 12297325
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/297325 | METHOD FOR RAPID DETECTION OF LYMPHATIC FILARIASIS | Apr 9, 2007 | Abandoned |
Array
(
[id] => 5264436
[patent_doc_number] => 20090117121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Pseudomonas Aeruginosa Outer Membrane Protein PA0427'
[patent_app_type] => utility
[patent_app_number] => 12/225821
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12629
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117121.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225821
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225821 | Pseudomonas aeruginosa outer membrane protein PA0427 | Mar 29, 2007 | Issued |
Array
(
[id] => 6096232
[patent_doc_number] => 20110003339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'Pathogenic Escherichia Coli Associated Protein'
[patent_app_type] => utility
[patent_app_number] => 11/693665
[patent_app_country] => US
[patent_app_date] => 2007-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15349
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003339.pdf
[firstpage_image] =>[orig_patent_app_number] => 11693665
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/693665 | Pathogenic Escherichia coli associated protein | Mar 28, 2007 | Issued |
Array
(
[id] => 42036
[patent_doc_number] => 07780966
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Artificial invaplex'
[patent_app_type] => utility
[patent_app_number] => 11/727486
[patent_app_country] => US
[patent_app_date] => 2007-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15337
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/780/07780966.pdf
[firstpage_image] =>[orig_patent_app_number] => 11727486
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/727486 | Artificial invaplex | Mar 26, 2007 | Issued |
Array
(
[id] => 4484562
[patent_doc_number] => 07883711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Use of polypeptides having antimicrobial activity'
[patent_app_type] => utility
[patent_app_number] => 12/282429
[patent_app_country] => US
[patent_app_date] => 2007-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17306
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/883/07883711.pdf
[firstpage_image] =>[orig_patent_app_number] => 12282429
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/282429 | Use of polypeptides having antimicrobial activity | Mar 19, 2007 | Issued |
Array
(
[id] => 6437902
[patent_doc_number] => 20100144041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => ' L-Arabinose Fermenting Yeast'
[patent_app_type] => utility
[patent_app_number] => 11/912493
[patent_app_country] => US
[patent_app_date] => 2007-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 17244
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144041.pdf
[firstpage_image] =>[orig_patent_app_number] => 11912493
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/912493 | L-arabinose fermenting yeast | Mar 18, 2007 | Issued |
Array
(
[id] => 4651063
[patent_doc_number] => 20080038319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Transformed Bacteria Producing CS6 Antigens as Vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/682648
[patent_app_country] => US
[patent_app_date] => 2007-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5917
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038319.pdf
[firstpage_image] =>[orig_patent_app_number] => 11682648
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/682648 | Transformed bacteria producing CS6 antigens as vaccines | Mar 5, 2007 | Issued |
Array
(
[id] => 132387
[patent_doc_number] => 07695948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'Antibodies that bind TNF-α converting enzyme'
[patent_app_type] => utility
[patent_app_number] => 11/709436
[patent_app_country] => US
[patent_app_date] => 2007-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11478
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/695/07695948.pdf
[firstpage_image] =>[orig_patent_app_number] => 11709436
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/709436 | Antibodies that bind TNF-α converting enzyme | Feb 20, 2007 | Issued |
Array
(
[id] => 5112477
[patent_doc_number] => 20070196392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Development of a Chlamydia sp. vaccine strain'
[patent_app_type] => utility
[patent_app_number] => 11/708620
[patent_app_country] => US
[patent_app_date] => 2007-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13569
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196392.pdf
[firstpage_image] =>[orig_patent_app_number] => 11708620
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/708620 | Development of a Chlamydia sp. vaccine strain | Feb 19, 2007 | Issued |
Array
(
[id] => 9761739
[patent_doc_number] => 08846058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Shiga toxoid chimeric proteins'
[patent_app_type] => utility
[patent_app_number] => 12/279423
[patent_app_country] => US
[patent_app_date] => 2007-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12831
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12279423
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279423 | Shiga toxoid chimeric proteins | Feb 15, 2007 | Issued |
Array
(
[id] => 6440776
[patent_doc_number] => 20100104516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'USE OF FLAGELLIN TO PREVENT AND TREAT GRAM NEGATIVE BACTERIAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 12/279671
[patent_app_country] => US
[patent_app_date] => 2007-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11479
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20100104516.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279671
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279671 | Use of flagellin to prevent and treat gram negative bacterial infection | Feb 14, 2007 | Issued |
Array
(
[id] => 8421328
[patent_doc_number] => 08277816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Bacillus anthracis antigens, vaccine compositions, and related methods'
[patent_app_type] => utility
[patent_app_number] => 11/706576
[patent_app_country] => US
[patent_app_date] => 2007-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 25817
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11706576
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/706576 | Bacillus anthracis antigens, vaccine compositions, and related methods | Feb 12, 2007 | Issued |
Array
(
[id] => 4608605
[patent_doc_number] => 07993860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-09
[patent_title] => 'Polypeptides recognized by anti-Trichinella antibodies, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/278595
[patent_app_country] => US
[patent_app_date] => 2007-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 8866
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/993/07993860.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278595
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278595 | Polypeptides recognized by anti-Trichinella antibodies, and uses thereof | Feb 6, 2007 | Issued |
Array
(
[id] => 5015786
[patent_doc_number] => 20070258994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Immunomodulatory formulations and methods for use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/703890
[patent_app_country] => US
[patent_app_date] => 2007-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26059
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20070258994.pdf
[firstpage_image] =>[orig_patent_app_number] => 11703890
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/703890 | Immunomodulatory formulations and methods for use thereof | Feb 6, 2007 | Abandoned |
Array
(
[id] => 5514225
[patent_doc_number] => 20090214531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Methods and Compositions for Treating and Preventing Bacterial Infections'
[patent_app_type] => utility
[patent_app_number] => 12/223371
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11422
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214531.pdf
[firstpage_image] =>[orig_patent_app_number] => 12223371
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223371 | Methods and Compositions for Treating and Preventing Bacterial Infections | Jan 28, 2007 | Abandoned |
Array
(
[id] => 4988153
[patent_doc_number] => 20070154492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Method for Purifying Polysaccharides'
[patent_app_type] => utility
[patent_app_number] => 11/622906
[patent_app_country] => US
[patent_app_date] => 2007-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17267
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20070154492.pdf
[firstpage_image] =>[orig_patent_app_number] => 11622906
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/622906 | Method for purifying polysaccharides | Jan 11, 2007 | Issued |